When you’ve got two exits under your belt by the age of 26
In this week’s edition of The Interchange, we touch on M&As in the fintech space as AngelList nabbed a startup and Uplift got bought for less than it raised in venture funding. We get into those deals, and much more. Want to receive this in your inbox every Sunday? Sign
Read moreThe Best Figma Plugins to Enhance Your Design Workflow in 2023
In this article, we'll explore the top Figma plugins that every designer should consider using to enhance their design workflow in 2023. Continue reading The Best Figma Plugins to Enhance Your Design Workflow in 2023 on SitePoint.
Read moreThis week in food tech: New fund shows food investments are still simmering
If you’re adventurous with your food, or just like to keep up with the fast-moving food tech industry, here’s a roundup of this week’s stories and some notable news we weren’t able to cover. Supply Change Capital The venture capital fund madness we’ve seen all year has made its way
Read moreARPAbet and the Major mnemonic system
ARPAbet is a phonetic spelling system developed by— you guessed it—ARPA, before it became DARPA. The ARPAbet system is less expressive than IPA, but much easier for English speakers to understand. Every sound is encoded as one or two English letters. So, for example, the sound denoted ʒ in IPA
Read moreTwitter rebrands to ‘X,’ hackers infect Call of Duty, and foreign visitors to China go cashless
Hey, friends, welcome to Week in Review (WiR), TechCrunch’s roundup of the week in tech news. Life getting in the way of your daily TechCrunch habit? Not to worry. WiR will get you caught up in no time. This week, WiR covers the improving quality of AI porn generators and
Read moreIn AI-enabled drug discovery, there might be more than one winner
W elcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. Today, a look at Israel from three different angles: drug discovery, AI-enabled cybersecurity threats, and investor reactions to
Read moreWeekend Edition features Colin Rees and Daniel Rizzi, co-founders of We-Watch
We used to have a sign in our window. I remember it from when I was a teenager. As I was writing this, I was trying to bring the image to mind and a lot of memories ran through my mind. Originally, I grew up in some pretty tough neighbourhoods.
Read moreRuzsa distance
A few days ago I wrote about Jaccard distance, a way of defining a distance between sets. The Ruzsa distance is similar, except it defines the distance between two subsets of an Abelian group. Subset difference Let A and B be two subsets of an Abelian (commutative) group G. Then
Read moreAbundant opportunities for founders at TechCrunch Disrupt 2023
“Founders first” is the TechCrunch credo — this is the way — and you’ll find the very best and brightest minds in the startup ecosystem gathered at TechCrunch Disrupt 2023, taking place September 19–21 in San Francisco. This year, our programming spans nine stages, seven industries and dozens of breakout
Read moreDeal Dive: Cutting through the noise in a category clouded by catastrophic failure
Building a startup is hard enough but growing one in a category marred with Theranos-sized stigma is a new level of challenge. Vital Bio seems up for the test. The Toronto-based startup is building a machine, VitalOne, that can perform more than 50 blood tests — covering nearly all of
Read more